Oxygen-permeable microwell device maintains islet mass and integrity during shipping.

Endocr Connect · 2018 · PMC5861371 · PMID 29483160

Europe PMC DOI

hedged sentences

0.0670

closest p · 1.3× alpha

0.0670

boldest claim

The sentences

failed to reach significanceP = 0.067so close (0.05 < p ≤ 0.1)

Although this difference failed to reach significance ( P = 0.067), four of five independent experiments showed increased OCR values for islets shipped in the microwell device, with improvements ranging from approximately 19–58% compared to controls ( Supplementary Fig. 2C ).

also in 4,113 other papers

showed a trendno p-value reported

We also observed that islets shipped in the microwell device showed a trend toward improved OCRs ( Fig. 7G ) compared to tube control-shipped islets.

also in 53,322 other papers

a clear trendno p-value reported

We found that murine islets transported in the microwell device indeed showed improved viability according to FDA/PI staining and also a clear trend for improved OCR/DNA ratio, where 4 out of 5 shipments showed an improvement.

also in 19,460 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.